Geron

GERN • NASDAQ • Stock Fundamentals

Geron is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Harout Semerjian, with a market cap of $731.3M.

Market Cap$731.3M

Employees141.0

CEOHarout Semerjian

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026

Next EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Geron

Geron (GERN) has a market capitalization of $731.3M and trades on NASDAQ.

Geron has approximately 141 employees.